drugset
drugset / Trial / NCT05250947

Study Evaluating the Safety and Feasibility of Platelet-rich Plasma to Treat Facetogenic Low Back Pain

NCT05250947 ↗

Phase 1 Terminated 4 enrolled Matthew Pingree
NaSingle-groupOpen-labelTreatment

Summary

This study is being done to assess the safety of using the Angel Concentrated Platelet Rich Plasma System to process Platelet Rich Plasma (PRP) to treat arthritis of the low back (lumbar spondylosis).

Timeline

Start
2023-01-05
Primary completion
2024-05-20
Completion
2024-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 6 ml Other

Indications

spondylosis